Ian Cromwell
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
SurvdigitizeR: an algorithm for automated survival curve digitization.
Journal: BMC medical research methodology
Published: March 21, 2024
Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial.
Journal: Cancer medicine
Published: October 14, 2020
Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: March 05, 2020
A time-and-motion approach to micro-costing of high-throughput genomic assays.
Journal: Current oncology (Toronto, Ont.)
Published: November 03, 2016
Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis.
Journal: Current oncology (Toronto, Ont.)
Published: March 18, 2016
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.
Journal: The oncologist
Published: October 30, 2015
Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada.
Journal: BMC health services research
Published: September 10, 2015
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 09, 2014
'Real-world' health care priority setting using explicit decision criteria: a systematic review of the literature.
Journal: BMC health services research
Published: January 14, 2014
A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 12, 2012
Erlotinib or docetaxel for second-line treatment of non-small cell lung cancer: a real-world cost-effectiveness analysis.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 05, 2011
Last Updated: 09/26/2026